• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的息肉样脉络膜血管病变血管模式分类及其与临床结局的关系。

A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes.

机构信息

National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore Fundus Image Reading Center, National Healthcare Group Eye Institute, Singapore, Singapore.

National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.

出版信息

Br J Ophthalmol. 2014 Nov;98(11):1528-33. doi: 10.1136/bjophthalmol-2014-305059. Epub 2014 Jul 4.

DOI:10.1136/bjophthalmol-2014-305059
PMID:24997181
Abstract

PURPOSE

To propose a novel classification system for polypoidal choroidal vasculopathy (PCV), and compare the clinical outcomes among PCV subtypes.

METHODS

Consecutive treatment-naive patients with symptomatic PCV were managed over 5 years. PCV subtypes were classified based on indocyanine green angiography (ICGA) and fluorescein angiography (FA) characteristics.

RESULTS

Among 107 patients, 3 PCV subtypes were seen: Type A (interconnecting channels on ICGA) -22.4%; Type B (branching vascular network with no leakage) -24.3%; Type C (branching vascular network with late leakage on FA) -53.3%. The proportion of patients with best-corrected visual acuity (BCVA) ≥20/40 was highest in Type A, intermediate in Type B and lowest in Type C at all time points (80% vs 66.7% vs 7.7% at 5 years, p<0.001). The highest rate of moderate visual loss (loss of ≥3 lines) occurred in Type C PCV (57.7% vs 0% for Types B and A at 5 years, p<0.001). Risk factors for poor visual outcomes were PCV subtype (OR 53.7, p<0.001 for Type C and OR 13.7, p=0.023 for Type B compared to Type A) and age (OR 1.06, 95% CI 1.002 to 1.125, p=0.044).

CONCLUSIONS

The PCV subtype seen on initial presentation affects the long-term visual outcomes over a 5-year period.

摘要

目的

提出一种新的息肉样脉络膜血管病变(PCV)分类系统,并比较不同 PCV 亚型的临床结局。

方法

对 5 年内连续接受治疗的有症状 PCV 患者进行管理。根据吲哚菁绿血管造影(ICGA)和荧光素血管造影(FA)的特征对 PCV 亚型进行分类。

结果

在 107 例患者中,观察到 3 种 PCV 亚型:A型(ICGA 上的连通通道)-22.4%;B 型(无渗漏的分支血管网络)-24.3%;C 型(FA 上有晚期渗漏的分支血管网络)-53.3%。在所有时间点,最佳矫正视力(BCVA)≥20/40 的患者比例A型最高,B 型次之,C 型最低(5 年时分别为 80%、66.7%和 7.7%,p<0.001)。C 型 PCV 中度视力丧失(损失≥3 行)发生率最高(5 年时分别为 57.7%、0%和 A 型,p<0.001)。视力不良结局的危险因素是 PCV 亚型(与 A 型相比,C 型 OR 53.7,p<0.001;B 型 OR 13.7,p=0.023)和年龄(OR 1.06,95%CI 1.002 至 1.125,p=0.044)。

结论

初次就诊时所见的 PCV 亚型会影响 5 年内的长期视力结局。

相似文献

1
A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes.一种新的息肉样脉络膜血管病变血管模式分类及其与临床结局的关系。
Br J Ophthalmol. 2014 Nov;98(11):1528-33. doi: 10.1136/bjophthalmol-2014-305059. Epub 2014 Jul 4.
2
EVEREST Report 5: Clinical Outcomes and Treatment Response of Polypoidal Choroidal Vasculopathy Subtypes in a Multicenter, Randomized Controlled Trial.EVEREST 报告 5:多中心、随机对照试验中息肉样脉络膜血管病变亚型的临床结局和治疗反应。
Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):889-896. doi: 10.1167/iovs.17-22683.
3
Comparison of the outcomes of photodynamic therapy between two angiographic subtypes of polypoidal choroidal vasculopathy.息肉样脉络膜血管病变两种血管造影亚型的光动力治疗效果比较。
Ophthalmologica. 2014;232(2):92-6. doi: 10.1159/000360308. Epub 2014 Jun 27.
4
One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.日本患者年龄相关性黄斑变性和息肉样脉络膜血管病变的光动力疗法一年期疗效
Ophthalmology. 2008 Jan;115(1):141-6. doi: 10.1016/j.ophtha.2007.02.031. Epub 2007 Jun 20.
5
Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.维替泊芬光动力疗法治疗症状性息肉状脉络膜血管病变:一项前瞻性病例系列研究的一年结果
Ophthalmology. 2004 Aug;111(8):1576-84. doi: 10.1016/j.ophtha.2003.12.056.
6
Combined photodynamic therapy with intravitreal bevacizumab injections for polypoidal choroidal vasculopathy: long-term visual outcome.联合光动力疗法与玻璃体内注射贝伐单抗治疗息肉样脉络膜血管病变:长期视力结果。
Am J Ophthalmol. 2014 Mar;157(3):598-606.e1. doi: 10.1016/j.ajo.2013.11.015. Epub 2013 Nov 22.
7
Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration.迈向息肉状脉络膜血管病变的特定分类:特发性疾病还是年龄相关性黄斑变性的亚型。
Invest Ophthalmol Vis Sci. 2015 May;56(5):3187-95. doi: 10.1167/iovs.14-16236.
8
EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study.珠穆朗玛峰研究报告3:息肉状脉络膜血管病变的诊断挑战。从珠穆朗玛峰研究中的筛查失败中吸取的教训。
Graefes Arch Clin Exp Ophthalmol. 2016 Oct;254(10):1923-1930. doi: 10.1007/s00417-016-3333-y. Epub 2016 May 3.
9
Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types.吲哚菁绿血管造影和光相干断层扫描结果支持将息肉样脉络膜血管病变分为两型。
Acta Ophthalmol. 2013 Sep;91(6):e474-81. doi: 10.1111/aos.12110. Epub 2013 Jul 15.
10
Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.用于治疗伴有息肉样脉络膜新生血管的新生血管性年龄相关性黄斑变性的选择性光动力疗法
Retina. 2007 Sep;27(7):825-31. doi: 10.1097/IAE.0b013e31804b3f70.

引用本文的文献

1
Review on classification of polypoidal choroidal vasculopathy.息肉样脉络膜血管病变的分类综述。
Int Ophthalmol. 2024 Nov 12;44(1):427. doi: 10.1007/s10792-024-03338-9.
2
Clinical variations of polypoidal choroidal vasculopathy: A cohort study from Japan and the USA.息肉样脉络膜血管病变的临床变异:来自日本和美国的队列研究。
Sci Rep. 2023 Mar 23;13(1):4800. doi: 10.1038/s41598-023-31649-x.
3
Different Morphology of Branching Neovascular Network in Polypoidal Choroidal Vasculopathy: A Swept-Source Optical Coherence Tomography Angiography Study.
息肉状脉络膜血管病变中分支状新生血管网络的不同形态:一项扫频源光学相干断层扫描血管造影研究
J Clin Med. 2023 Jan 17;12(3):742. doi: 10.3390/jcm12030742.
4
Polypoidal Choroidal Vasculopathy: An Update on Diagnosis and Treatment.息肉样脉络膜血管病变:诊断与治疗的最新进展
Clin Ophthalmol. 2023 Jan 5;17:53-70. doi: 10.2147/OPTH.S385827. eCollection 2023.
5
Evolution of Polypoidal Lesions after Treatment of Polypoidal Choroidal Vasculopathy.息肉样脉络膜血管病变治疗后息肉样病变的演变
Ophthalmol Sci. 2021 Nov 17;2(1):100082. doi: 10.1016/j.xops.2021.100082. eCollection 2022 Mar.
6
Characteristics and treatment response of polypoidal choroidal vasculopathy in highly myopic eyes.高度近视眼中息肉样脉络膜血管病变的特征和治疗反应。
Eye (Lond). 2023 Jun;37(9):1910-1915. doi: 10.1038/s41433-022-02251-8. Epub 2022 Oct 7.
7
Optical coherence tomography in diagnosing polypoidal choroidal vasculopathy. Looking into the future: a systematic review and meta-analysis.光学相干断层扫描在诊断息肉样脉络膜血管病变中的应用。展望未来:一项系统评价与荟萃分析。
Int J Retina Vitreous. 2022 Feb 28;8(1):14. doi: 10.1186/s40942-022-00365-5.
8
Polypoidal Choroidal Vasculopathy Diagnosis and Neovascular Activity Evaluation Using Optical Coherence Tomography Angiography.基于光学相干断层扫描血管造影的息肉样脉络膜血管病变的诊断和新生血管活动评估。
Biomed Res Int. 2021 Nov 16;2021:1637377. doi: 10.1155/2021/1637377. eCollection 2021.
9
Clinical features and prognosis of polypoidal choroidal vasculopathy with different morphologies of branching vascular network on optical coherence tomography angiography.光学相干断层扫描血管造影下不同分支血管网络形态的息肉状脉络膜血管病变的临床特征和预后。
Sci Rep. 2021 Sep 8;11(1):17848. doi: 10.1038/s41598-021-97340-1.
10
Comparison of Polypoidal Choroidal Vasculopathy Lesion Sizes Measured on Multicolor Imaging and Indocyanine Green Angiography.多光谱成像与吲哚菁绿血管造影测量的息肉样脉络膜血管病变病灶大小比较。
Transl Vis Sci Technol. 2021 Feb 5;10(2):35. doi: 10.1167/tvst.10.2.35.